‘
ArisGlobal, a Miami, FL-based provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, acquired Amplexor Life Sciences (LS), a Novo Mesto, Slovenia-based global provider of regulatory, quality, and safety software solutions to pharmaceutical, biotechnology, and medical device companies.
The amount of the deal was not disclosed.
The acquisition will accelerate both companies’ roadmaps and increase efficiency in bringing new therapies to the market. The integration of the regulatory product lines will bring a distinct set of benefits to customers. LifeSphere users are now gaining access to enhanced publishing and labeling capabilities; in addition to a Quality Management System (QMS) from Amplexor. Amplexor LS’s regulatory customers can now connect to even wider functionality through LifeSphere including access to Safety, Medical Affairs and Clinical solutions. The integration is subject to customary government approvals that are expected to be completed in the next 60 days.
Amplexor Life Sciences is a provider of regulatory, quality and safety software solutions, serving pharmaceutical, biotechnology and medical device companies. Its holistic Life Sciences Suite of solutions helps life sciences organizations to be efficient with launching products and entering new markets quickly while ensuring quality, efficacy and safety through support to product lifecycle processes, data and content management.
Led by Mike Gordon, chief executive officer, ArisGlobal specializes in delivering Drug Safety solutions worldwide enabling Life Sciences companies develop and bring new products to market. Headquartered in the United States, the company has regional offices in Europe, India, Japan, and China.
FinSMEs
01/03/2023